Prime Capital Investment Advisors, LLC Recursion Pharmaceuticals, Inc. Transaction History
Prime Capital Investment Advisors, LLC
- $7.33 Billion
- Q2 2025
A detailed history of Prime Capital Investment Advisors, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 30,346 shares of RXRX stock, worth $164,171. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,346
Previous 18,854
60.95%
Holding current value
$164,171
Previous $99,000
54.55%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RXRX
# of Institutions
357Shares Held
293MCall Options Held
3.28MPut Options Held
3.24M-
Vanguard Group Inc Valley Forge, PA36.1MShares$195 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33MShares$178 Million1.38% of portfolio
-
Baillie Gifford & CO24.2MShares$131 Million0.1% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$93.6 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$79.4 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $976M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...